Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Real-World Outcomes of Rivaroxaban Treatment in Patients with Both Nonvalvular Atrial Fibrillation and a History of Ischemic Stroke/Transient Ischemic Attack.

Minematsu K, Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Miyamoto S, Murakawa Y, Takeichi M, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S.

Cerebrovasc Dis. 2019 Oct 2:1-8. doi: 10.1159/000502883. [Epub ahead of print]

PMID:
31578012
2.

Real-world outcomes of rivaroxaban treatment in elderly Japanese patients with nonvalvular atrial fibrillation.

Kitazono T, Ikeda T, Ogawa S, Nakagawara J, Minematsu K, Miyamoto S, Murakawa Y, Cavaliere M, Hayashi Y, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S.

Heart Vessels. 2019 Sep 6. doi: 10.1007/s00380-019-01487-x. [Epub ahead of print]

PMID:
31492970
3.

Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings.

Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Minematsu K, Miyamoto S, Murakawa Y, Iwashiro S, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S.

J Thromb Thrombolysis. 2019 Nov;48(4):653-660. doi: 10.1007/s11239-019-01934-6.

PMID:
31432451
4.

Real-world outcomes of rivaroxaban treatment in patients with nonvalvular atrial fibrillation and worsening renal function.

Nakagawara J, Ikeda T, Ogawa S, Kitazono T, Minematsu K, Miyamoto S, Murakawa Y, Takeichi M, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S.

J Cardiol. 2019 Dec;74(6):501-506. doi: 10.1016/j.jjcc.2019.06.003. Epub 2019 Jul 29.

PMID:
31371191
5.

Two Case Reports of Intravenous Leiomyomatosis with Hyaluronan Expression.

Konishi H, Koh I, Shiroma N, Kidani Y, Urabe S, Tanaka N, Hirata E, Arihiro K, Kudo Y.

Case Rep Obstet Gynecol. 2018 Jul 17;2018:4039183. doi: 10.1155/2018/4039183. eCollection 2018.

6.

Cytokine Secreting Microparticles Engineer the Fate and the Effector Functions of T-Cells.

Majedi FS, Hasani-Sadrabadi MM, Kidani Y, Thauland TJ, Moshaverinia A, Butte MJ, Bensinger SJ, Bouchard LS.

Adv Mater. 2018 Feb;30(7). doi: 10.1002/adma.201703178. Epub 2018 Jan 8.

7.

Addendum: Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment.

Kitagawa Y, Ohkura N, Kidani Y, Vandenbon A, Hirota K, Kawakami R, Yasuda K, Motooka D, Nakamura S, Kondo M, Taniuchi I, Kohwi-Shigematsu T, Sakaguchi S.

Nat Immunol. 2017 Oct 18;18(11):1270. doi: 10.1038/ni1117-1270a.

PMID:
29044238
8.

A distinct subpopulation of CD25- T-follicular regulatory cells localizes in the germinal centers.

Wing JB, Kitagawa Y, Locci M, Hume H, Tay C, Morita T, Kidani Y, Matsuda K, Inoue T, Kurosaki T, Crotty S, Coban C, Ohkura N, Sakaguchi S.

Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):E6400-E6409. doi: 10.1073/pnas.1705551114. Epub 2017 Jul 11.

9.

Reviewing the impact of lipid synthetic flux on Th17 function.

Kidani Y, Bensinger SJ.

Curr Opin Immunol. 2017 Jun;46:121-126. doi: 10.1016/j.coi.2017.03.012. Epub 2017 Jun 29. Review.

PMID:
28668661
10.

Erratum: Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment.

Kitagawa Y, Ohkura N, Kidani Y, Vandenbon A, Hirota K, Kawakami R, Yasuda K, Motooka D, Nakamura S, Kondo M, Taniuchi I, Kohwi-Shigematsu T, Sakaguchi S.

Nat Immunol. 2017 Mar 22;18(4):474. doi: 10.1038/ni0417-474d. No abstract available.

PMID:
28323270
11.

Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment.

Kitagawa Y, Ohkura N, Kidani Y, Vandenbon A, Hirota K, Kawakami R, Yasuda K, Motooka D, Nakamura S, Kondo M, Taniuchi I, Kohwi-Shigematsu T, Sakaguchi S.

Nat Immunol. 2017 Feb;18(2):173-183. doi: 10.1038/ni.3646. Epub 2016 Dec 19. Erratum in: Nat Immunol. 2017 Mar 22;18(4):474. Nat Immunol. 2017 Oct 18;18(11):1270.

12.

Bruton Tyrosine Kinase Inhibition Attenuates Liver Damage in a Mouse Warm Ischemia and Reperfusion Model.

Palumbo T, Nakamura K, Lassman C, Kidani Y, Bensinger SJ, Busuttil R, Kupiec-Weglinski J, Zarrinpar A.

Transplantation. 2017 Feb;101(2):322-331. doi: 10.1097/TP.0000000000001552.

13.

Modulating Cholesterol Homeostasis to Build a Better T Cell.

Kidani Y, Bensinger SJ.

Cell Metab. 2016 Jun 14;23(6):963-964. doi: 10.1016/j.cmet.2016.05.015.

14.

The therapeutic effect of CD133(+) cells derived from human umbilical cord blood on neonatal mouse hypoxic-ischemic encephalopathy model.

Kidani Y, Miki Y, Nomimura N, Minakawa S, Tanaka N, Miyoshi H, Wakabayashi K, Kudo Y.

Life Sci. 2016 Jul 15;157:108-115. doi: 10.1016/j.lfs.2016.06.004. Epub 2016 Jun 7.

PMID:
27287679
15.

Role of Prostaglandin D2 and DP1 Receptor on Japanese Cedar Pollen-Induced Allergic Rhinitis in Mice.

Nakano Y, Kidani Y, Goto K, Furue S, Tomita Y, Inagaki N, Tanaka H, Shichijo M.

J Pharmacol Exp Ther. 2016 May;357(2):258-63. doi: 10.1124/jpet.115.229799. Epub 2016 Mar 4.

PMID:
26945086
16.

Determination of cleavage site of Reelin between its sixth and seventh repeat and contribution of meprin metalloproteases to the cleavage.

Sato Y, Kobayashi D, Kohno T, Kidani Y, Prox J, Becker-Pauly C, Hattori M.

J Biochem. 2016 Mar;159(3):305-12. doi: 10.1093/jb/mvv102. Epub 2015 Oct 21.

PMID:
26491063
17.

Identification of a novel gene (Apq1) from the indica rice cultivar 'Habataki' that improves the quality of grains produced under high temperature stress.

Murata K, Iyama Y, Yamaguchi T, Ozaki H, Kidani Y, Ebitani T.

Breed Sci. 2014 Dec;64(4):273-81. doi: 10.1270/jsbbs.64.273. Epub 2014 Dec 1.

18.

Genetic dissection of black grain rice by the development of a near isogenic line.

Maeda H, Yamaguchi T, Omoteno M, Takarada T, Fujita K, Murata K, Iyama Y, Kojima Y, Morikawa M, Ozaki H, Mukaino N, Kidani Y, Ebitani T.

Breed Sci. 2014 Jun;64(2):134-41. doi: 10.1270/jsbbs.64.134. Epub 2014 Jun 1.

19.

Gene expression in the Gitr locus is regulated by NF-κB and Foxp3 through an enhancer.

Tone Y, Kidani Y, Ogawa C, Yamamoto K, Tsuda M, Peter C, Waldmann H, Tone M.

J Immunol. 2014 Apr 15;192(8):3915-24. doi: 10.4049/jimmunol.1302174. Epub 2014 Mar 14.

20.

Lipids rule: resetting lipid metabolism restores T cell function in systemic lupus erythematosus.

Kidani Y, Bensinger SJ.

J Clin Invest. 2014 Feb;124(2):482-5. doi: 10.1172/JCI74141. Epub 2014 Jan 27.

21.

Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity.

Kidani Y, Elsaesser H, Hock MB, Vergnes L, Williams KJ, Argus JP, Marbois BN, Komisopoulou E, Wilson EB, Osborne TF, Graeber TG, Reue K, Brooks DG, Bensinger SJ.

Nat Immunol. 2013 May;14(5):489-99. doi: 10.1038/ni.2570. Epub 2013 Apr 7.

22.

An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity.

Williams KJ, Argus JP, Zhu Y, Wilks MQ, Marbois BN, York AG, Kidani Y, Pourzia AL, Akhavan D, Lisiero DN, Komisopoulou E, Henkin AH, Soto H, Chamberlain BT, Vergnes L, Jung ME, Torres JZ, Liau LM, Christofk HR, Prins RM, Mischel PS, Reue K, Graeber TG, Bensinger SJ.

Cancer Res. 2013 May 1;73(9):2850-62. doi: 10.1158/0008-5472.CAN-13-0382-T. Epub 2013 Feb 25.

23.

Liver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunity.

Kidani Y, Bensinger SJ.

Immunol Rev. 2012 Sep;249(1):72-83. doi: 10.1111/j.1600-065X.2012.01153.x. Review.

24.

Emergence of distinct multiarmed immunoregulatory antigen-presenting cells during persistent viral infection.

Wilson EB, Kidani Y, Elsaesser H, Barnard J, Raff L, Karp CL, Bensinger S, Brooks DG.

Cell Host Microbe. 2012 May 17;11(5):481-91. doi: 10.1016/j.chom.2012.03.009.

25.

Differential localization of sphingomyelin synthase isoforms in neurons regulates sphingomyelin cluster formation.

Kidani Y, Ohshima K, Sakai H, Kohno T, Baba A, Hattori M.

Biochem Biophys Res Commun. 2012 Jan 20;417(3):1014-7. doi: 10.1016/j.bbrc.2011.12.079. Epub 2011 Dec 22.

PMID:
22209789
26.

Coordinate regulation of neutrophil homeostasis by liver X receptors in mice.

Hong C, Kidani Y, A-Gonzalez N, Phung T, Ito A, Rong X, Ericson K, Mikkola H, Beaven SW, Miller LS, Shao WH, Cohen PL, Castrillo A, Tontonoz P, Bensinger SJ.

J Clin Invest. 2012 Jan;122(1):337-47. doi: 10.1172/JCI58393. Epub 2011 Dec 12.

28.

Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.

Yanagie H, Hisa T, Ogata A, Miyazaki A, Nonaka Y, Nishihira T, Osada I, Sairennji T, Sugiyama H, Furuya Y, Kidani Y, Takamoto S, Takahashi H, Eriguchi M.

Biomed Pharmacother. 2009 Sep;63(8):553-60. doi: 10.1016/j.biopha.2008.04.006. Epub 2008 May 27.

PMID:
18571892
29.

Ampulla (Takotsubo) cardiomyopathy caused by secondary adrenal insufficiency in ACTH isolated deficiency.

Sakihara S, Kageyama K, Nigawara T, Kidani Y, Suda T.

Endocr J. 2007 Aug;54(4):631-6. Epub 2007 Jul 31.

30.

Which is a better position for insertion of a high thoracic epidural catheter: sitting or lateral decubitus?

Nishi M, Usukaura A, Kidani Y, Tsubokawa T, Yamamoto K.

J Cardiothorac Vasc Anesth. 2006 Oct;20(5):656-8. Epub 2006 Aug 8.

PMID:
17023283
31.

Sevoflurane pretreatment inhibits endotoxin-induced shock in rats.

Kidani Y, Taniguchi T, Kanakura H, Takemoto Y, Tsuda K, Yamamoto K.

Anesth Analg. 2005 Oct;101(4):1152-6.

PMID:
16192536
32.

Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.

Noji M, Kizu R, Takeda Y, Akiyama N, Yoshizaki I, Eriguchi M, Kidani Y.

Biomed Pharmacother. 2005 Jun;59(5):224-9.

PMID:
15919175
33.

Effects of milnacipran on the inhibitory postsynaptic potential in neurons of the rat locus coeruleus.

Kuwahata T, Kidani Y, Ishimatsu M, Akasu T.

Kurume Med J. 2004;51(3-4):185-91.

34.

[Effects of milnacipran on neuronal excitability and synaptic transmission in neurons of the rat locus coeruleus].

Kidani Y, Ishimatsu M, Kuwahata T, Yamashita Y, Akasu T, Matsuishi T.

No To Hattatsu. 2005 Jan;37(1):31-8. Japanese.

PMID:
15675357
35.

Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats.

Taniguchi T, Kidani Y, Kanakura H, Takemoto Y, Yamamoto K.

Crit Care Med. 2004 Jun;32(6):1322-6.

PMID:
15187514
36.

The dose-related effects of ketamine on mortality and cytokine responses to endotoxin-induced shock in rats.

Taniguchi T, Takemoto Y, Kanakura H, Kidani Y, Yamamoto K.

Anesth Analg. 2003 Dec;97(6):1769-72. Erratum in: Anesth Analg. 2004 Jan;98(1):122.

PMID:
14633557
37.

Effects of ketamine and propofol on the ratio of interleukin-6 to interleukin-10 during endotoxemia in rats.

Taniguchi T, Kanakura H, Takemoto Y, Kidani Y, Yamamoto K.

Tohoku J Exp Med. 2003 Jun;200(2):85-92.

38.

Effects of methylphenidate on the inhibitory postsynaptic potential in rat locus coeruleus neurons.

Kuwahata T, Ishimatsu M, Kidani Y, Akasu T.

Kurume Med J. 2002;49(4):185-90.

39.

Effects of methylphenidate on the membrane potential and current in neurons of the rat locus coeruleus.

Ishimatsu M, Kidani Y, Tsuda A, Akasu T.

J Neurophysiol. 2002 Mar;87(3):1206-12.

40.

Antitumor effects of a new lipophilic platinum compound, trans-bis(n-valerato)(1R,2R-cyclohexanediamine)(oxalato)platinum(IV), in mice.

Saegusa Y, Eriguchi M, Kidani Y, Matsuzawa A, Takeda Y.

Anticancer Res. 2001 Jan-Feb;21(1A):245-52.

PMID:
11299742
41.

A new orally active antitumor 1R,2R-cyclohexanediamine-platinum(IV) complex: trans-(n-valerato)chloro(1R,2R-cyclohexanediamine) (oxalato)platinum(IV).

Kizu R, Nakanishi T, Hayakawa K, Matsuzawa A, Eriguchi M, Takeda Y, Akiyama N, Tashiro T, Kidani Y.

Cancer Chemother Pharmacol. 1999;43(2):97-105.

PMID:
9923814
42.

Significance of water solubility in the gastrointestinal absorption of trans-bis(n-valerato)(1R,2R-cyclohexanediamine)(oxalato)platinum(IV), an orally active antitumor platinum complex, and its analogs.

Kizu R, Nakanishi T, Yamamoto S, Hayakawa K, Matsuzawa A, Eriguchi M, Takeda Y, Akiyama N, Kidani Y.

Anticancer Drugs. 1998 Feb;9(2):167-74.

PMID:
9510503
43.

An orally active antitumor cyclohexanediamine-Pt(IV) complex: trans,cis,cis-bis(n-valerato)(oxalato)(1R,2R-cyclohexane diamine)Pt(IV).

Kizu R, Nakanishi T, Miyazaki M, Tashiro T, Noji M, Matsuzawa A, Eriguchi M, Takeda Y, Akiyama N, Kidani Y.

Anticancer Drugs. 1996 May;7(3):248-56.

PMID:
8791997
44.

Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers.

Pendyala L, Kidani Y, Perez R, Wilkes J, Bernacki RJ, Creaven PJ.

Cancer Lett. 1995 Nov 6;97(2):177-84.

PMID:
7497460
45.

Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand.

Yamashita T, Hirose J, Noji M, Saito R, Tomida H, Kidani Y.

Biol Pharm Bull. 1993 Oct;16(10):1014-8.

PMID:
8287030
46.
47.

The crystal structure and absolute configuration of the antitumor platinum complex trans(OH)-Pt(OH)2(malonato)(1R,2R-cyclohexanediamine).

Goto M, Hirose J, Noji M, Lee KI, Saito R, Kidani Y.

Chem Pharm Bull (Tokyo). 1992 Apr;40(4):1022-4.

PMID:
1525931
48.

Zinc deficient bovine erythrocyte superoxide dismutase has low specific activity.

Hirose J, Kano H, Kidani Y, Iwamoto H, Hiromi K.

Chem Pharm Bull (Tokyo). 1992 Feb;40(2):506-8.

PMID:
1606652
49.

Cytotoxicity of asymmetric platinum complexes against L-1210 cells. Effect of bulky substituents.

Hirano T, Inagaki K, Fukai T, Alink M, Nakahara H, Kidani Y.

Chem Pharm Bull (Tokyo). 1990 Oct;38(10):2850-2.

PMID:
2076570
50.

Supplemental Content

Loading ...
Support Center